Latest Biotech News

Roche is pressing its case with the EMA for its Duchenne muscular dystrophy gene therapy Elevidys (delandistrogene moxeparvovec) by initiating a further global Phase 3 trial. The study aims to...

Neomorph raised $100 million in a Series B round to advance its oral molecular glue degrader NEO-811 through clinical development in clear cell renal cell carcinoma. The company is funding an...

Transformative Biotech said it is advancing extraction-free PCR chemistry aimed at cutting a major bottleneck in molecular testing: the sample extraction step. The approach is being marketed to...

Beeline Medicines launched with a $300 million Series A led by Bain Capital to pursue a portfolio of five in-licensed programs from Bristol Myers Squibb targeting immune-mediated diseases. The...

Kailera Therapeutics priced an upsized US biopharma IPO, raising $625 million and setting a new record for U.S. drug-company debut. The company priced 39 million shares at $16 apiece, with a full...

10x Genomics unveiled Atera, a new spatial instrument announced at AACR, positioning it as a whole-transcriptome spatial biology platform designed to reduce common trade-offs across existing...

A clinical trial reported progress on using donor-derived regulatory dendritic cells (DCreg) to modulate immune response after living-donor liver transplantation while enabling earlier withdrawal...

Trevi Therapeutics raised $150 million through a planned equity offering as it looks to fund pipeline development and clinical progress. The report indicates the company plans to float more than...

10x Genomics used the AACR meeting circuit to launch Atera, a new spatial instrument aimed at whole-transcriptome profiling at scale. The company positioned Atera as closing performance gaps seen...

Revolution Medicines’ latest Phase 3 pancreatic cancer result pushed the company back into acquisition focus, with reporting that the market valuation and deal appetite shifted after the survival...

Gene therapy’s growing clinical footprint drew another spotlight as the Breakthrough Prize Foundation handed the Life Sciences prize to two pioneering teams. One effort, led by...

FDA’s Pharmacy Compounding Advisory Committee is set to convene July 23–24 to consider whether seven peptides used for unproven indications should be added to products that can be compounded. The...

Roche outlined a new strategy to support EMA approval for Elevidys (delandistrogene moxeparvovec), signaling it will pursue additional global Phase 3 evidence for Duchenne muscular dystrophy. The...

Neomorph raised $100 million in a Series B to push its molecular glue degrader NEO-811 through an ongoing Phase I/II trial in clear cell renal cell carcinoma. The company’s approach targets ARNT...

Alamar Biosciences began trading on Nasdaq under ticker ALMR after pricing its initial public offering at $17 per share, raising roughly $220 million in gross proceeds. The proteomics company...

Kailera Therapeutics priced an upsized IPO raising $625 million, positioning the offering as a record-setting debut for U.S. biotech. The company plans to use the proceeds to fund global clinical...

Researchers reported wastewater-based epidemiology that can detect the emergence of clinically significant and drug-resistant Candida auris strains within healthcare settings. The work, attributed...

At AACR, Ultima Genomics presented early TRACERx MRD results using its ppmSeq technology, describing ultra-sensitive ctDNA detection in plasma at low single-digit parts-per-million. The program is...

Researchers led by Chang, Moshi, Nguyen and colleagues reported in Nature Communications (2026) that wastewater-based epidemiology can detect clinically significant, drug-resistant Candida auris...

A 20-year cohort study reported that metabolically healthy obesity (MHO) is still associated with substantial cardiovascular risk over time. The findings shift the narrative from “metabolically...